These reports were based on SSc patients, and there have been no previous reports on the prevalence and clinical characteristics of anti-fibrillarin antibody-positive IIP patients; we found that anti-fibrillarin antibody positivity is associated with AE in IIP patients. Here, FBL is linked to systemic sclerosis.